Cardiomyopathy: molecular and immunological aspects (review)

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Idiopathic cardiomyopathies encompass hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
• Familial occurrence is common, particularly in HCM, suggesting a genetic basis.
• Understanding the molecular underpinnings is crucial for diagnosis and treatment.

Purpose of the Study:

• To review the molecular basis of idiopathic cardiomyopathies.
• To identify genetic abnormalities associated with familial HCM and DCM.
• To explore other potential etiological factors including viral and immunological aspects.

Main Methods:

• Review of existing literature on molecular aspects of cardiomyopathies.
• Identification of gene mutations in sarcomeric and cytoskeletal proteins.
• Analysis of potential viral and immunological triggers.

Main Results:

• Nine sarcomeric gene abnormalities identified in familial HCM (e.g., beta cardiac myosin heavy chain, cardiac troponin T/I, titin).
• Cytoskeletal gene abnormalities (desmin, laminin A/C) and delta-sarcoglycan mutations found in familial/sporadic DCM.
• Mitochondrial gene mutations implicated in both HCM and DCM.
• Chronic viral myocarditis (e.g., Hepatitis C virus) and immunological factors (autoantibodies) are potential contributors.

Conclusions:

• Genetic mutations are central to the pathogenesis of familial cardiomyopathies.
• Specific gene defects correlate with clinical presentation and risk (e.g., sudden death in HCM).
• Multifactorial etiologies involving genetic, viral, and immunological factors are likely in idiopathic cardiomyopathies.